Yavi M

Experimental Therapeutics & Pathophysiology Branch, Division of Intramural Research Program, National Institute of Mental Health, Bethesda, MD, USA.

5 papers · 1 preprint

ArticleKetamine

Convergent neuroimmune signaling underlying rapid antidepressant response to ketamine and psychedelics.

Jones GH, Gilbert JR, Johnston JN +20

Europe PMC2026
ArticlePsilocybin

Time-dependent effects of rapid-acting antidepressants in iPSC-derived neurons from treatment-resistant depression and healthy volunteers.

Johnston JN, Jones GH, Peng S +12

Europe PMC2026
PreprintPsilocybin

Time-Dependent Effects of Rapid-Acting Antidepressants in iPSC-Derived Neurons from Treatment-Resistant Depression and Healthy Volunteers

Johnston J, Jones G, Peng S +12

Europe PMC2026
ArticleKetamine

Mindfulness, music, visual occlusion in ketamine therapy for depression: do they change outcomes? A qualitative and quantitative analysis of a randomized controlled trial.

Kheirkhah M, McDonald N, Aepfelbacher J +17

Europe PMC2025
ArticleKetamine

Exploring the impact of music on response to ketamine/esketamine: A scoping review.

Kheirkhah M, Nugent AC, Livinski AA +11

Europe PMC2024
ArticleKetamine

Long-term follow-up of participants in ketamine clinical trials for mood disorders.

Hurst KT, Vogeley A, Greenstein DK +6

Europe PMC2024